Saturday, September 5, 2026

Huang: U.S. AI Edge Over China Is Barely Hanging On

Nvidia CEO Jensen Huang warns China's AI capabilities are catching up to the U.S., urging policy changes to boost domestic tech development.

ARRESTED: Madman Tries To WALK Into HELL—South Korean Man Charged After North Korea Border Break

A man in his 50s was arrested at the Unification Bridge for trying to enter North Korea, violating military protection laws.

North Korea Signals Nuclear-Ready Rocket Force Ahead of Party Summit

North Korea showcased new 600mm rocket launchers ahead of the 9th Workers' Party Congress, signaling enhanced defense strategies.

Tag: TG-C

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Kolon TissueGene Says TG-C Fails to Meet Statistical Significance in First Phase 3 Trial Analysis in U.S.

Kolon TissueGene's Phase 3 trial for TG-C showed pain relief but lacked statistical significance compared to placebo; further analysis underway.

Top News

- Our Sponsors Ad -

Follow us